動物用藥品市場規模、佔有率和成長分析：按產品類型、動物種類、給藥途徑、最終用戶、銷售管道和地區分類－2026-2033年產業預測

2024 年全球動物用藥品市場價值為 532.5 億美元，預計到 2033 年將從 2025 年的 572.4 億美元成長到 1020.9 億美元，在預測期（2026-2033 年）內複合年成長率為 7.5%。

全球動物用藥品市場的發展動力源自於這些產品在保障動物健康方面發揮的關鍵作用，而動物健康直接影響食品安全和公共衛生。全球蛋白質需求的成長和寵物飼養率的上升是推動市場擴張的主要因素。受更嚴格的監管和人們對抗菌素抗藥性日益成長的認知的驅動，獸藥市場正經歷著從頻譜抗生素和驅蟲藥向靶向疫苗、生物製藥和診斷技術創新的顯著轉變。這種轉變凸顯了預防和診斷解決方案的必要性。此外，新興市場家禽產量激增和寵物飼養率上升等趨勢也進一步鞏固了市場動態。因此，製造商正日益專注於創新、標靶型動物用藥品，並投入更多資源進行研發，以滿足不斷變化的市場需求。

全球動物用藥品市場按產品類型、動物種類、給藥途徑、最終用戶、銷售管道和地區進行細分。依產品類型分類，市場分為疫苗、抗生素、驅蟲藥、抗發炎藥和其他產品。依動物種類分類，市場分為家畜、伴侶動物和其他動物。依給藥途徑分類，市場分為口服、注射（如腸外給藥）、外用和其他給藥途徑。依最終用戶分類，市場分為獸醫院、藥局、畜牧場和其他用戶。依銷售管道分類，市場分為動物用藥品批發商、直銷、線上獸藥店和其他通路。依地區分類，市場分為北美、歐洲、亞太、拉丁美洲以及中東和非洲。

全球動物用藥品市場的成長要素

全球動物用藥品市場的主要促進因素之一是寵物數量的成長以及人們對動物健康和福利意識的提高。隨著個人和家庭飼養寵物，對先進獸醫護理和有效藥物的需求不斷成長，以確保這些動物的健康和長壽。此外，寵物「人性化」的趨勢使得飼主更願意投資購買高品質的動物產品，這推動了藥品解決方案的創新和發展。同時，為確保食品安全和生產效率，畜牧業疾病預防和治療的需求也顯著促進了市場擴張。

全球動物用藥品市場的限制因素

全球動物用藥品市場的主要限制因素之一是政府機構日益嚴格的監管和核准流程。雖然這些法規通常旨在確保動物用藥品的安全性和有效性，但它們也可能導致新產品核准漫長且成本高昂。這可能會使製藥公司在研發投入方面猶豫不決，尤其是在小眾動物用藥品，最終限制創新並延緩新治療方法的上市。這些障礙會阻礙整個動物用藥品產業的成長潛力，並影響獸醫和寵物飼主獲得所需產品。

全球動物用藥品市場趨勢

全球動物用藥品市場正經歷顯著的發展趨勢，這主要得益於「同一健康」計劃的強化。該計劃旨在促進動物和人類健康領域各相關人員相關者之間的協同夥伴關係。這種綜合方法透過實現全面的疾病監測和加強合理使用抗菌藥物，有助於提升整體公共衛生水準。隨著這些合作關係的拓展，在通用感染疾病疫苗、診斷和治療方法的合作研發途徑正在不斷湧現，同時也圖動物福利。數據共用的加強、政策的協調以及公私合營正在推動創新，使製藥公司能夠提供多方面的解決方案和可擴展的預防項目，從而豐富市場格局。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球動物用藥品市場規模：依產品類型分類

• 疫苗
• 抗生素
• 殺蟲劑
• 抗發炎藥
• 其他

全球動物用藥品市場規模：依動物類型分類

• 家畜
  • 家禽
  • 牛
• 伴侶動物
  • 狗和貓
  • 馬
• 其他

全球動物用藥品市場規模：依給藥途徑分類

• 口服
• 腸外
• 外用
• 其他

全球動物用藥品市場規模：依最終用戶分類

• 動物醫院
• 藥局
• 畜牧場
• 其他

全球動物用藥品市場規模：依銷售管道分類

• 動物用藥品批發商
• 直銷
• 在線動物用藥品房
• 其他

全球動物用藥品市場規模：依地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• Zoetis
• Boehringer Ingelheim
• Merck Animal Health（MSD）
• Elanco Animal Health
• Ceva Sante Animale
• Virbac
• Vetoquinol
• Dechra Pharmaceuticals
• Neogen Corporation
• Phibro Animal Health
• Huvepharma
• Kyoritsu Seiyaku
• Bimeda
• Aratana Therapeutics
• Heska Corporation
• Parnell Living Science
• Norbrook
• Kela
• Ourofino Saude Animal
• Indovax

結論與建議

Global Veterinary Pharmaceuticals Market size was valued at USD 53.25 Billion in 2024 and is poised to grow from USD 57.24 Billion in 2025 to USD 102.09 Billion by 2033, growing at a CAGR of 7.5% during the forecast period (2026-2033).

The global veterinary pharmaceuticals market is driven by the critical role these products play in ensuring animal health, directly impacting food security and public health. Growing global demand for protein and rising pet ownership are primary factors fueling market expansion. There has been a notable transition from broad-spectrum antibiotics and antiparasitics to targeted vaccines, biologics, and diagnostic innovations in response to tightening regulations and increased awareness of antimicrobial resistance. This shift highlights the need for preventive and diagnostic solutions. Furthermore, trends like the surge in poultry production in emerging markets and enhanced pet adoption rates underscore the market's dynamics. As a result, manufacturers are increasingly allocating resources towards research and development, focusing on innovative, targeted veterinary products to meet evolving demands.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Veterinary Pharmaceuticals market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Veterinary Pharmaceuticals Market Segments Analysis

Global veterinary pharmaceuticals market is segmented into product type, animal type, route of administration, end-user, sales channel and region. Based on product type, the market is segmented into vaccines, antibiotics, parasiticides, anti-inflammatory drugs and others. Based on animal type, the market is segmented into livestock, companion animals and others. Based on route of administration, the market is segmented into oral, parenteral, topical and others. Based on end-user, the market is segmented into veterinary hospitals, pharmacies, livestock farms and others. Based on sales channel, the market is segmented into veterinary distributors, direct sales, online veterinary pharmacies and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Veterinary Pharmaceuticals Market

One of the key market drivers for the global veterinary pharmaceuticals market is the increasing pet ownership and the rising awareness of animal health and welfare. As more individuals and families adopt pets, there is a growing demand for advanced veterinary care and effective pharmaceuticals to ensure the health and longevity of these animals. Additionally, the rising trend of pet humanization has led to owners willing to invest in high-quality veterinary products, driving innovation and development in pharmaceutical solutions. Furthermore, the need to prevent and treat diseases in livestock for food safety and production efficiency significantly contributes to the market's expansion.

Restraints in the Global Veterinary Pharmaceuticals Market

One significant market restraint for the global veterinary pharmaceuticals market is the increasing regulatory scrutiny and stringent approval processes imposed by government agencies. These regulations are often aimed at ensuring the safety and efficacy of veterinary medications but can result in lengthy and costly approval timelines for new products. This can deter pharmaceutical companies from investing in research and development, particularly for niche veterinary products, ultimately limiting innovation and slowing down the introduction of new therapies into the market. Such barriers may impede the overall growth potential of the veterinary pharmaceuticals sector, affecting availability and access for veterinarians and pet owners.

Market Trends of the Global Veterinary Pharmaceuticals Market

The Global Veterinary Pharmaceuticals market is witnessing a significant trend driven by the rising One Health collaboration, which encourages synergetic partnerships among animal and human health stakeholders. This integrated approach facilitates comprehensive disease surveillance and bolsters antimicrobial stewardship initiatives, thereby enhancing overall public health. As these collaborations expand, they pave the way for coordinated research and development efforts in zoonotic vaccines, diagnostics, and therapeutics, while simultaneously promoting animal welfare. Enhanced data-sharing practices and policy harmonization, along with public-private initiatives, are fostering innovation, enabling pharmaceutical companies to deliver multispecies solutions and scalable prevention programs, thus enriching the market landscape.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Veterinary Pharmaceuticals Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Vaccines
• Antibiotics
• Parasiticides
• Anti-inflammatory Drugs
• Others

Global Veterinary Pharmaceuticals Market Size by Animal Type & CAGR (2026-2033)

• Market Overview
• Livestock
  • Poultry
  • Cattle
• Companion Animals
  • Dogs and Cats
  • Horses
• Others

Global Veterinary Pharmaceuticals Market Size by Route of Administration & CAGR (2026-2033)

• Market Overview
• Oral
• Parenteral
• Topical
• Others

Global Veterinary Pharmaceuticals Market Size by End-User & CAGR (2026-2033)

• Market Overview
• Veterinary Hospitals
• Pharmacies
• Livestock Farms
• Others

Global Veterinary Pharmaceuticals Market Size by Sales Channel & CAGR (2026-2033)

• Market Overview
• Veterinary Distributors
• Direct Sales
• Online Veterinary Pharmacies
• Others

Global Veterinary Pharmaceuticals Market Size & CAGR (2026-2033)

• North America (Product Type, Animal Type, Route of Administration, End-User, Sales Channel)
  • US
  • Canada
• Europe (Product Type, Animal Type, Route of Administration, End-User, Sales Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Animal Type, Route of Administration, End-User, Sales Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Animal Type, Route of Administration, End-User, Sales Channel)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Animal Type, Route of Administration, End-User, Sales Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Zoetis
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boehringer Ingelheim
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck Animal Health (MSD)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elanco Animal Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ceva Sante Animale
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Virbac
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vetoquinol
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dechra Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Neogen Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Phibro Animal Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Huvepharma
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kyoritsu Seiyaku
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bimeda
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aratana Therapeutics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Heska Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Parnell Living Science
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Norbrook
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kela
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ourofino Saude Animal
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Indovax
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations